Nowak Radosław P, Che Jianwei, Ferrao Silas, Kong Nikki R, Liu Hu, Zerfas Breanna L, Jones Lyn H
Center for Protein Degradation, Dana-Farber Cancer Institute 360 Longwood Avenue Boston MA USA.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School Boston MA USA
RSC Med Chem. 2023 Jan 26;14(3):501-506. doi: 10.1039/d2md00347c. eCollection 2023 Mar 22.
Thalidomide and its derivatives are molecular glues that bind cereblon (CRBN), a component of an E3 ubiquitin ligase complex, and mediate protein interactions with neosubstrates resulting in their polyubiquitination and proteasomal degradation. The structural features of neosubstrate binding have been elucidated that highlight key interactions with a β-hairpin degron containing a glycine, which is present in a wide-range of proteins, including zinc-finger transcription factors such as IKZF1, and the translation termination factor GSPT1. Here, we profile 14 closely-related thalidomide derivatives in CRBN occupancy, and IKZF1 and GSPT1 degradation cell-based assays, and use crystal structures, computational docking and molecular dynamics to delineate subtle structure-activity relationships. Our findings will enable the rational design of CRBN modulators in the future, and help avoid the degradation of GSPT1 which is broadly cytotoxic.
沙利度胺及其衍生物是分子胶,可结合E3泛素连接酶复合物的一个组分cereblon(CRBN),并介导与新底物的蛋白质相互作用,导致其多聚泛素化和蛋白酶体降解。已阐明新底物结合的结构特征,突出了与含有甘氨酸的β-发夹降解子的关键相互作用,该降解子存在于多种蛋白质中,包括锌指转录因子如IKZF1和翻译终止因子GSPT1。在此,我们在基于细胞的CRBN占据以及IKZF1和GSPT1降解测定中分析了14种密切相关的沙利度胺衍生物,并使用晶体结构、计算对接和分子动力学来描绘微妙的构效关系。我们的发现将有助于未来合理设计CRBN调节剂,并有助于避免广泛具有细胞毒性的GSPT1的降解。